Global Endovascular Abdominal Aortic Aneurysm (AAA) Market to Reach US$3.8 Billion by 2030
The global market for Endovascular Abdominal Aortic Aneurysm (AAA) estimated at US$3.0 Billion in the year 2024, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Stent Graft, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$2.7 Billion by the end of the analysis period. Growth in the Synthetic Fabric Graft segment is estimated at 2.6% CAGR over the analysis period.
The U.S. Market is Estimated at US$806.9 Million While China is Forecast to Grow at 7.6% CAGR
The Endovascular Abdominal Aortic Aneurysm (AAA) market in the U.S. is estimated at US$806.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$773.8 Million by the year 2030 trailing a CAGR of 7.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.
What Technological Shifts Are Redefining the Treatment Landscape for AAA?
The management of abdominal aortic aneurysms (AAA) has seen a paradigm shift from open surgical repair to minimally invasive techniques, primarily led by endovascular aneurysm repair (EVAR). Technological advancements in stent graft design, catheter delivery systems, and imaging guidance have enabled EVAR to become the dominant intervention method in many high-income healthcare systems. The core of EVAR technology lies in modular stent grafts that can be introduced via femoral artery access and deployed precisely at the aneurysm site, effectively excluding the weakened vessel wall from systemic circulation. The shift toward percutaneous, suture-less access and low-profile devices has significantly expanded the treatable patient population, including those with higher surgical risk.
Next-generation EVAR systems are emphasizing anatomical adaptability and long-term sealing performance. The development of fenestrated and branched endografts has allowed surgeons to treat aneurysms that were once considered unsuitable for conventional EVAR due to short or angulated necks, or involvement of visceral branches. Innovations such as polymer-based sealing rings, repositionable grafts, and integrated imaging markers are addressing common complications like endoleaks, migration, and access issues. Additionally, the emergence of intraoperative imaging systems, including 3D fusion imaging and robotic-assisted navigation, is streamlining procedural accuracy and reducing contrast and radiation exposure. These technological strides are not only optimizing procedural outcomes but also influencing treatment guidelines and surgeon preferences globally.
Which Patient Demographics and Risk Profiles Are Driving Clinical Demand?
The burden of abdominal aortic aneurysms is rising, largely influenced by the aging global population and prevalence of modifiable risk factors such as smoking, hypertension, and hyperlipidemia. AAAs are most commonly diagnosed in men aged 65 and older, though incidence among older women is increasingly recognized in epidemiological studies. As a result, screening programs have been introduced in several developed countries targeting at-risk populations, particularly male smokers over the age of 65. The broader implementation of ultrasound-based screening has led to earlier detection of asymptomatic aneurysms, thus expanding the pool of patients eligible for elective EVAR procedures before rupture occurs.
In high-risk surgical populations-such as the elderly or those with comorbidities like chronic obstructive pulmonary disease (COPD), renal dysfunction, or coronary artery disease-EVAR offers a viable treatment alternative to traditional open repair. This has driven demand across tertiary hospitals, ambulatory surgical centers, and even hybrid operating rooms tailored for vascular interventions. Furthermore, the growing number of patients requiring reintervention after initial EVAR due to graft degeneration or aneurysm sac enlargement is creating a secondary demand channel for newer, more durable graft technologies. The inclusion of women in AAA risk stratification protocols and the detection of aneurysms through incidental imaging are also contributing to procedural growth, though anatomical differences still pose challenges for universal device applicability.
How Are Regional Ecosystems and Market Access Influencing Uptake?
North America and Western Europe remain the most mature markets for EVAR, driven by high procedural volumes, advanced hospital infrastructure, and favorable reimbursement policies. The U.S. has been a leading adopter of EVAR, supported by the presence of major medical device manufacturers, continuous clinical trials, and a skilled vascular surgery workforce. In the European context, countries like Germany, the UK, and the Netherlands demonstrate strong procedural integration within public health systems, with EVAR accounting for over 70% of elective AAA repairs. Government-funded screening initiatives in these regions further fuel patient identification and referral for endovascular treatment.
Asia-Pacific is emerging as a key growth frontier, particularly in Japan, China, and South Korea, where the aging population and urbanization are increasing the incidence of vascular diseases. Japan has been at the forefront in terms of technological adoption, with robust procedural experience and widespread use of custom fenestrated devices. In China, expanding healthcare infrastructure and the development of domestic device manufacturers are enabling rapid market expansion. However, reimbursement disparities and training limitations remain challenges in many emerging economies. In Latin America and parts of the Middle East, adoption is slower but growing, especially in private hospitals catering to higher-income patient segments. Market access strategies such as device leasing, surgical training programs, and hybrid OR installation support are proving effective in these underpenetrated regions.
What Are the Key Forces Powering the Growth of the EVAR Market?
The growth in the endovascular abdominal aortic aneurysm (AAA) market is driven by several factors that collectively shape technology development, procedural adoption, and patient access worldwide. Chief among them is the increasing global prevalence of AAAs, a trend exacerbated by demographic aging, lifestyle-related risk factors, and expanded screening practices. As asymptomatic aneurysms are increasingly detected at an earlier stage, elective EVAR is being prioritized as a safer, less invasive alternative to open surgery. This shift is underpinned by continued innovation in stent graft systems that offer enhanced conformability, sealing capacity, and durability, even in anatomically complex cases.
Regulatory pathways and payer structures are also accelerating growth. With FDA approvals for next-gen devices and CE marks expanding to cover advanced fenestrated and branched solutions, clinical adoption is rising in both traditional and niche anatomical segments. The movement toward value-based healthcare models is aligning well with EVAR's lower complication rates, shorter hospital stays, and reduced postoperative morbidity. Hospitals and surgical centers are investing in hybrid ORs and integrated imaging systems to support these procedures, indicating confidence in the long-term utility of endovascular approaches.
Additionally, industry players are increasingly focused on training and education, launching simulation-based programs and global surgeon networks to standardize procedural expertise. The combination of telehealth for follow-up care and wearable devices for postoperative surveillance is further enriching the treatment ecosystem. Meanwhile, increasing investments in R&D-especially into bioresorbable graft components and AI-enabled imaging tools-suggest that EVAR technology is still in a phase of active evolution. These multifactorial drivers point toward sustained expansion in both procedure volumes and device innovation, firmly establishing EVAR as the dominant modality in AAA management for the foreseeable future.
SCOPE OF STUDY:
The report analyzes the Endovascular Abdominal Aortic Aneurysm (AAA) market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Product Type (Stent Graft, Synthetic Fabric Graft); End-Use (Hospital End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 41 Featured) -
Abbott Laboratories
Artivion Inc.
Bentley InnoMed GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
Braile Biomedica
Cardinal Health Inc.
Cook Medical LLC
Cordis Corporation
CryoLife Inc.
Edwards Lifesciences Corp.
Endologix LLC
Getinge AB
JOTEC GmbH
LeMaitre Vascular Inc.
Lifetech Scientific Corp.
Lombard Medical Ltd.
Medtronic plc
MicroPort Scientific Corp.
Terumo Corporation
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Tariff Impact on Global Supply Chain Patterns
Endovascular Abdominal Aortic Aneurysm (AAA) - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Prevalence of Aortic Aneurysms Among Aging Population Drives Demand for Endovascular Repair
Technological Advancements in Stent Graft Designs Propel Growth in Minimally Invasive AAA Treatments
Expansion of Screening Programs for Aortic Aneurysms Throws Spotlight on Early Detection and Elective Repair
Improved Outcomes and Lower Morbidity Rates Strengthen Business Case for Endovascular Over Open Surgery
Integration of 3D Imaging and Navigation Technologies Enhances Precision in Stent Graft Placement
Development of Fenestrated and Branched Stent Grafts Expands Addressable Patient Pool With Complex Anatomy
Increasing Adoption of EVAR in Ambulatory Surgical Centers Spurs Procedural Volume Growth
Regulatory Approvals for Next-Generation Grafts Accelerate Innovation and Clinical Uptake
Surge in High-Risk and Comorbid Patients Strengthens Preference for Endovascular Approaches
Collaboration With Vascular Surgeons Fuels Device Design Improvements and Workflow Integration
Clinical Data Supporting Long-Term Durability of EVAR Devices Encourages Broader Adoption
Growing Emphasis on Post-EVAR Surveillance Supports Demand for Follow-Up Imaging Technologies
Patient Awareness Campaigns and Screening Initiatives Spur Elective Procedure Rates
Payer Reimbursement for Minimally Invasive Aneurysm Repairs Strengthens Financial Accessibility
Increasing Use of Contrast-Free and Low-Radiation Imaging Expands EVAR Safety in Renal-Impaired Patients
Emerging Use of AI in Aneurysm Morphology Assessment Drives Personalized Device Selection
Global Burden of Cardiovascular Disease Supports Government-Funded AAA Screening Programs
Focus on Device Miniaturization and Flexibility Enhances Access in Narrow Iliac Arteries
Expansion of Training and Simulation Programs Improves Vascular Surgeon Expertise in EVAR Techniques
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Endovascular Abdominal Aortic Aneurysm (AAA) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 4: World 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Stent Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Stent Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 7: World 16-Year Perspective for Stent Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Synthetic Fabric Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Synthetic Fabric Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 10: World 16-Year Perspective for Synthetic Fabric Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 13: World 16-Year Perspective for Hospital End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 20: USA Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 21: USA Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 22: USA 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 23: USA Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 24: USA Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 25: USA 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
CANADA
TABLE 26: Canada Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 27: Canada Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 28: Canada 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 29: Canada Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 31: Canada 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
JAPAN
Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 32: Japan Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 33: Japan Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 34: Japan 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 35: Japan Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 37: Japan 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
CHINA
Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 38: China Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: China Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 40: China 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 41: China Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 42: China Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 43: China 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
EUROPE
Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 44: Europe Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 45: Europe Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 46: Europe 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
TABLE 47: Europe Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 49: Europe 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 52: Europe 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
FRANCE
Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 53: France Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 54: France Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 55: France 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 56: France Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: France Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 58: France 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
GERMANY
Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 59: Germany Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 60: Germany Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 61: Germany 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 62: Germany Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 64: Germany 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
ITALY
TABLE 65: Italy Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 66: Italy Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 67: Italy 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 68: Italy Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 70: Italy 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
UNITED KINGDOM
Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 71: UK Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 72: UK Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 73: UK 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 74: UK Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: UK Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 76: UK 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
SPAIN
TABLE 77: Spain Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 78: Spain Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 79: Spain 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 80: Spain Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: Spain Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 82: Spain 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
RUSSIA
TABLE 83: Russia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 84: Russia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 85: Russia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 86: Russia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Russia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 88: Russia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
REST OF EUROPE
TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 90: Rest of Europe Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 91: Rest of Europe 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 94: Rest of Europe 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
ASIA-PACIFIC
Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 96: Asia-Pacific Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 97: Asia-Pacific 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 100: Asia-Pacific 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 103: Asia-Pacific 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
AUSTRALIA
Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 104: Australia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Australia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 106: Australia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 107: Australia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 108: Australia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 109: Australia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
INDIA
Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 110: India Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 111: India Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 112: India 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 113: India Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 114: India Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 115: India 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
SOUTH KOREA
TABLE 116: South Korea Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 117: South Korea Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 118: South Korea 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 119: South Korea Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 120: South Korea Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 121: South Korea 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 123: Rest of Asia-Pacific Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 126: Rest of Asia-Pacific Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
LATIN AMERICA
Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 128: Latin America Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 129: Latin America Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 130: Latin America 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
TABLE 131: Latin America Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 132: Latin America Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 133: Latin America 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 134: Latin America Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 135: Latin America Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 136: Latin America 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
ARGENTINA
TABLE 137: Argentina Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 138: Argentina Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 139: Argentina 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 140: Argentina Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 141: Argentina Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 142: Argentina 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
BRAZIL
TABLE 143: Brazil Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 144: Brazil Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 145: Brazil 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 146: Brazil Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 147: Brazil Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 148: Brazil 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
MEXICO
TABLE 149: Mexico Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 150: Mexico Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 151: Mexico 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 152: Mexico Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 153: Mexico Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 154: Mexico 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
REST OF LATIN AMERICA
TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 156: Rest of Latin America Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 157: Rest of Latin America 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 159: Rest of Latin America Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 160: Rest of Latin America 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
MIDDLE EAST
Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 161: Middle East Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 162: Middle East Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 163: Middle East 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
TABLE 164: Middle East Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 165: Middle East Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 166: Middle East 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 167: Middle East Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 168: Middle East Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 169: Middle East 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
IRAN
TABLE 170: Iran Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 171: Iran Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 172: Iran 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 173: Iran Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 174: Iran Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 175: Iran 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
ISRAEL
TABLE 176: Israel Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 177: Israel Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 178: Israel 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 179: Israel Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 180: Israel Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 181: Israel 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
SAUDI ARABIA
TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 183: Saudi Arabia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 184: Saudi Arabia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 186: Saudi Arabia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 187: Saudi Arabia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 188: UAE Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 189: UAE Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 190: UAE 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 191: UAE Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 192: UAE Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 193: UAE 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
REST OF MIDDLE EAST
TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 195: Rest of Middle East Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 196: Rest of Middle East 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 198: Rest of Middle East Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 199: Rest of Middle East 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
AFRICA
Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 200: Africa Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 201: Africa Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 202: Africa 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
TABLE 203: Africa Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 204: Africa Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 205: Africa 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030